Clinical and dosimetric aspects in concurrent radiotherapy with CDK4/6 inhibitors in breast cancer

被引：0
|
作者：
Rebegea, Laura Florentina [1 ,2 ,3 ]
Ilie, Ana Maria [1 ]
Anghel, Rodica [4 ]
Lungu, Mihaela [2 ,5 ]
Dumitru, Mihaela Emilia [1 ]
机构：
[1] Sfantul Apostol Andrei Emergency Clin Hosp, Dept Radiotherapy, Galati 800578, Romania
[2] Univ Galatzi, Fac Med & Pharm, Dept Clin Med, Galati, Romania
[3] Univ Galatzi, Res Ctr Field Med & Pharmaceut Sci, ReFORM UDJ, Galati, Romania
[4] Carol Davila Univ Med & Pharm, Dept Clin Med, Bucharest, Romania
[5] Sfantul Apostol Andrei Emergency Clin Hosp, Dept Neurol, Galati 800578, Romania
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
radiotherapy; CDK4/6i; toxicities;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2226
引用
收藏
页码：S632 / S633
页数：3
相关论文
共 50 条
  • [31] Advances in CDK4 and 6 Inhibitors: Transforming Breast Cancer Treatment
    Ballestin, Sonia Santander
    Labena, Maria Abadia
    Avedillo-Salas, Ana
    Continente, Cristina Marco
    Blazquez, Marina Arribas
    Bartolome, Maria Jose Luesma
    CANCERS, 2025, 17 (05)
  • [32] Current Therapeutic Progress of CDK4/6 Inhibitors in Breast Cancer
    Wu, Yanmei
    Zhang, Yu
    Pi, Hao
    Sheng, Yuan
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3477 - 3487
  • [33] Position paper on CDK4/6 inhibitors in early breast cancer
    Gnant, Michael
    Singer, Christian F.
    Rinnerthaler, Gabriel
    Pfeiler, Georg
    Egle, Daniel
    Balic, Marija
    Bartsch, Rupert
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (02) : 135 - 144
  • [34] Accessibility of CDK4/6 inhibitors for breast cancer patients in the Netherlands
    Luyendijk, Marianne
    Blommestein, Hedwig
    Jager, Agnes
    Siesling, Sabine
    Uyl-de Groot, Carin
    CANCER RESEARCH, 2022, 82 (04)
  • [35] Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
    Piezzo, Michela
    Cocco, Stefania
    Caputo, Roberta
    Cianniello, Daniela
    Di Gioia, Germira
    Di Lauro, Vincenzo
    Fusco, Giuseppina
    Martinelli, Claudia
    Nuzzo, Francesco
    Pensabene, Matilde
    De Laurentiis, Michelino
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 23
  • [36] Cardiac complications of CDK4/6 inhibitors for breast cancer.
    Master, Samip R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] CDK4/6 Inhibitors : Promising Opportunities beyond Breast Cancer
    Lim, Joline S. J.
    Turner, Nicholas C.
    Yap, Timothy A.
    CANCER DISCOVERY, 2016, 6 (07) : 697 - 699
  • [38] CDK4/6 inhibitors in advanced breast cancer, what is beyond?
    Mohammed, Amrallah A.
    Rashied, Hanaa
    Elsayed, Fifi Mostafa
    ONCOLOGY REVIEWS, 2019, 13 (02) : 125 - 133
  • [39] Clinical considerations of CDK4/6 inhibitors in HER2 positive breast cancer
    Zhang, Cui
    Zhou, Fulin
    Zou, Jiali
    Fang, Yanman
    Liu, Yuncong
    Li, Libo
    Hou, Jing
    Wang, Guanghui
    Wang, Hua
    Lai, Xiaolian
    Xie, Lu
    Jiang, Jia
    Yang, Can
    Huang, Yisidan
    Chen, Yingji
    Zhang, Hanqun
    Li, Yong
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [40] Clinical outcomes of CDK4/6 inhibitors in patients with bone only metastatic breast cancer
    Mardani, Mahta
    Noordeen, Suleyman
    Clifton, Katherine
    Ma, Cynthia
    Luo, Jingqin
    Xi, Jing
    Bagegni, Nusayba
    Ademuyiwa, Foluso
    Suresh, Rama
    Frith, Ashley
    Davis, Andrew
    Bose, Ron
    Peterson, Lindsay
    Thomas, Shana
    Tao, Yu
    Kobayashi, Takayuki
    Xiang, Jingyu
    Xu, Yalin
    Su, Xinming
    Weilbaecher, Katherine
    CANCER RESEARCH, 2024, 84 (09)
12345